M029
Overview:
SHP1 inhibitors for immunotherapy. Currently under investigation in veterinary oncology trials.
Status:
Purdue Faculty:
Research Articles:
Discovery of a First‐in‐Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity